CLINICAL_TRIALS
other
· 2025-12-31
Clinical Trial Update: Evaluate the Pharmacokinetic Interaction and the Safety of AD-2321 and AD-2322 [Phase 1]
Summary
A Phase 1 trial to evaluate pharmacokinetic interactions and safety of AD-2321 and AD-2322 in hypertension; the study is not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Addpharma Inc. | Conditions: Hypertension | Phase 1 | Status: NOT_YET_RECRUITING